High flow nasal cannula versus non-invasive ventilation in the treatment of acute exacerbations of COPD with acute-moderate hypercapnic respiratory failure
- PMID: 39300587
- PMCID: PMC11411755
- DOI: 10.1186/s13054-024-05094-9
High flow nasal cannula versus non-invasive ventilation in the treatment of acute exacerbations of COPD with acute-moderate hypercapnic respiratory failure
Conflict of interest statement
The authors declare that they have no competing interests.
Comment on
-
High flow nasal cannula oxygen therapy versus non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: a randomized controlled non-inferiority trial.Crit Care. 2024 Jul 18;28(1):250. doi: 10.1186/s13054-024-05040-9. Crit Care. 2024. PMID: 39026242 Free PMC article. Clinical Trial.
References
-
- Tan D, Wang B, Cao P, Wang Y, Sun J, Geng P, et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: a randomized controlled non-inferiority trial. Crit Care. 2024;28:250. - PMC - PubMed
-
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017;49:1700214. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
